Phase 2 Dose-finding Studies with MCP and Modelling Techniques

Innovations in statistics, programming and data management are changing the very nature of clinical development. Cytel thought-leaders reveal cutting-edge techniques that streamline and truly accelerate product developmental at the clinical trial, program and portfolio level. Featuring, Simulation and biomarkers speeding development at Merck, Adaptive trial design methodology and software demonstrations, Leading independent authorities and Cytel speakers at User Group Meetings. www.cytel.com +1 .617.661.2011